BMO Maintains Buy Rating and $190 Price Target on Protagonist Therapeutics, Citing Icotyde Potential and Pipeline Catalysts
at www.tipranks.com (Tue, 10-Nov 1:06 PM)
Analysts Offer Insights on Healthcare Companies: McKesson (MCK) and Protagonist Therapeutics (PTGX)
at www.tipranks.com (Tue, 10-Nov 10:00 AM)
Analysts Offer Insights on Healthcare Companies: InMed Pharmaceuticals (INM), Protagonist Therapeutics (PTGX) and Johnson & Johnson (JNJ)
at www.tipranks.com (Tue, 10-Nov 3:00 AM)
